Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
Sponsor: Southern Medical University, China
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Southern Medical University, China
See all terminations from Southern Medical University, China
This NA trial investigates ACE Inhibitor and Angiotensin II Type 1 Receptor Blockers and is currently terminated or withdrawn. Southern Medical University, China leads this study, which shows 4 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2017 — Jan 2021 [monthly]
Terminated NA
First recorded
Jan 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Southern Medical University, China
For direct contact, visit the study record on ClinicalTrials.gov .